LOXL1 and neoplasm: Additionally, with a goal of predicting the survival probability for CRC patients in clinic, a risk estimation nomogram based on the above two independent risk factors (tumor stage and LOXL1) was established and scores were calculated to predict 1-, 3- and 5-year OS for individual patient (Fig. 1I).